Luye Pharma to spin off Singapore unit in $500m listing
Luye Medical, the healthcare services arm of Luye Life Sciences Group, has enlisted three banks to lead its IPO of about $500m in Singapore.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: